Major Depressive Disorder (MDD)

MDD
Intro
Major depressive disorder (MDD), all the more usually known as depression, is a mental issue classified by a steady and industrious low temperament that is supplemented by low self-regard and by lost interest or joy in regularly activities. As with majorly depressed individuals in general, the borderline patient is likely to exhibit familiar symptoms of major depression, such as fluctuation of weight, irregular sleep patterns, sadness, loneliness, lack of energy, anxiety, feelings of guilt and worthlessness, suicidal gestures or ideation of suicide, lack of interest in once enjoyable activities and persistent irritability (Beatson & Rao, 2012). For example, a man who has missed work or school in light of their discouragement, or
At least one of the symptoms must be either depressed mood or loss of interest or pleasure (Fava & Kendler, 2000). Depression affects millions of people. But every patient with depression responds to treatment differently. Individuals that suffer from MDD have shorter life expectancies than those without MMD, in part because of greater susceptibility to medical illnesses and suicide. It is unclear whether medications affect the risk of suicide ("Major Depressive Disorder — NEJM", 2016). The three treatments that are going to be critically analysed are:

1. A minority are treated with electroconvulsive therapy (ECT).
2. Selective serotonin reuptake inhibitors (SSRIs)
3. Cognitive Behavioural Treatment (CBT)

Treatment 1 – Electroconvulsive
& Kendler, K. (2000). Major Depressive Disorder. Neuron, 28(2), 335-341. http://dx.doi.org/10.1016/s0896-6273(00)00112-4
Major Depressive Disorder — NEJM. (2016). New England Journal of Medicine. Retrieved 11 May 2016, from http://www.nejm.org/doi/full/10.1056/NEJMra073096
SCOTT, J., PALMER, S., PAYKEL, E., TEASDALE, J., & HAYHURST, H. (2003). Use of cognitive therapy for relapse prevention in chronic depression: Cost-effectiveness study. The British Journal Of Psychiatry, 182(3), 221-227. http://dx.doi.org/10.1192/bjp.182.3.221
Spielmans, G., Berman, M., Linardatos, E., Rosenlicht, N., Perry, A., & Tsai, A. (2013). Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes. Plos Med, 10(3), e1001403. http://dx.doi.org/10.1371/journal.pmed.1001403
SSRIs – Selective serotonin reuptake inhibitors. (2016). NPS MedicineWise. Retrieved 10 May 2016, from